Antibiotic resistance in Europe: the challenges ahead
Monnet, D.L., Suetens, C., Buksarova, A., Earnshaw, S., Gagliotti, C., Heuer, O., Magiorakos, A.P., Mantero, J., Marma, S., Navarro, Torne, A., Sodano, L., Weber, J.T., Weist, K.
Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): Results from the burden of communicable diseases in Europe study, European Union and European economic countries, 2009 to 2013
Cassini, A., Colzani, E., Pini, A., Mangen, M.-J.J., Plass, D., McDonald, S.A., Maringhini, G., van Lier, A., Haagsma, J.A., Havelaar, A.H., Kramarz, P., Kretzschmar, M.E.
Protective measures for humans against avian influenza a(H5N8) outbreaks in 22 European Union/European economic area countries and Israel, 2016–17
Adlhoch, C., Dabrera, G., Penttinen, P., Pebody, R.